Source: Annual Congress 2012 - Pulmonary injury and repair from alveolus to vessel walls
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Keane (Dublin, Ireland). Vascular density in fibrotic ILD: too much or not enough vessels?. Annual Congress 2012 - Pulmonary injury and repair from alveolus to vessel walls

Member's Comments

No comment yet.

Related content which might interest you: Vascular activity and vessel density in idiophatic interstitial pineumonias Source: Eur Respir J 2004; 24: Suppl. 48, 320s Year: 2004 Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration? Source: Eur Respir J, 56 (4) 2003167; 10.1183/13993003.03167-2020 Year: 2020 Plasticity of vascular progenitor cells: Implications in pulmonary vascular remodelling in COPD Source: Eur Respir Rev 2006; 15: 209-210 Year: 2006 Vanishing vessels aboding pulmonary disease: a role for VEGFR2 Source: Eur Respir J, 55 (4) 2000326; 10.1183/13993003.00326-2020 Year: 2020 Plasticity of vascular progenitor cells: implications in pulmonary vascular remodeling in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 803s Year: 2006 IL-17+ cells immunoexpression in systemic sclerosis pulmonary fibrosis Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Vascular endothelial growth factor (VEGF) as marker of pulmonary hypertension in children with asthma Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Relation between pulmonary arterial remodeling and parenchymal disease in severe COPD and interstitial lung disease patients Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Pulmonary vascular disease Source: HERMES Summer School 2014 - Educational material Year: 2014 Pulmonary hypertension: the science behind the disease spectrum Source: Eur Respir Rev 2012; 21: 19-26 Year: 2012 Pulmonary artery dilation and increased lung density in systemic sclerosis Source: International Congress 2015 – A more functional view of chest pathology Year: 2015 Vascular endothelial growth factor (VEGF) and airway inflammation in COPD. Correlation with pulmonary function Source: Eur Respir J 2006; 28: Suppl. 50, 653s Year: 2006 Smooth muscle microparticles as novel biomarkers of vascular remodelling and inflammation in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 The RANKL-OPG balance in pulmonary fibrosis Source: International Congress 2015 – Connective tissue disorders Year: 2015 Epithelial mesenchymal transition in fibroblastic foci of different fibrosing lung diseases: Repair or remodeling? Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis Year: 2013 The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations Source: Eur Respir Rev 2014; 23: 350-355 Year: 2014 Increased fibrinolytic mediators in IPF as potential contributors to pulmonary fibrosis and vascular remodeling Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Neutrophil vascular endothelial growth factor (VEGF) as a driving force for angiogenesis in bronchiectasis? Source: International Congress 2016 – New findings in mucosal immunology Year: 2016